Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label vaccines. Show all posts
Showing posts with label vaccines. Show all posts
Monday, May 07, 2012

Insight: Training immune system to fight cancer comes of age | Reuters

›
 Blogger's Note: not specific to ovarian cancer Insight: Training immune system to fight cancer comes of age | Reuters ".....W...
Thursday, April 19, 2012

JNCI J Natl Cancer Inst - audio/podcast - JNCI PODCAST News Summaries for Issue 9 The Efficacy of Cancer Vaccines - Dr. Jeffrey Schlom talks about therapeutic cancer vaccines

›
Blogger's Note: comments in interview include references to prostate, FAP (genetics/colorectal cancer) & high risk ovarian/breast;...
Friday, April 06, 2012

2011 Medical News ASCO: Abagovomab No Help in Ovarian Cancer - in Meeting Coverage, ASCO from MedPage Today

›
Medical News: ASCO: Abagovomab No Help in Ovarian Cancer - in Meeting Coverage, ASCO from MedPage Today " Abagovomab maintenance tr...
Monday, March 26, 2012

newswise: Pox Vaccines Extend Survival for Patients with Melanoma, Ovarian Cancer in U.S., German Studies

›
Pox Vaccines Extend Survival for Patients with Melanoma, Ovarian Cancer in U.S., German Studies Released: 3/26/2012 3:05 PM E...
Friday, March 09, 2012

open access: Expert Reviews - Outlining novel scenarios for improved therapeutic cancer vaccines: the PANVAC paradigm (ovarian/breast)

›
Expert Reviews - Expert Review of Vaccines - 11(3):275 - Full Text     Outlining novel scenarios for improved therapeutic cancer vaccines:...
Wednesday, March 07, 2012

DPX-Survivac vaccine - Biotech company raises $2.8 million for R&D | The Chronicle Herald

›
"Halifax biotechnology company Immunovaccine Inc. has raised $2.8 million in equity funding that will help the company push forward wi...
Tuesday, March 06, 2012

JNCI - The Challenges of Cancer Vaccines

›
The Challenges of Cancer Vaccines
Monday, March 05, 2012

phase 11 - Trial of Adjuvant FANG™ Vaccine for High Risk Stage IIIc Ovarian Cancer - Full Text View - ClinicalTrials.gov

›
Primary Outcome Measures: To determine and compare time to recurrence (TTR) [ Time Frame: Participants will be followed for life ...
Thursday, February 02, 2012

not yet recruiting - Phase 1 Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors - Full Text View - ClinicalTrials.gov

›
Wednesday, January 25, 2012

Search of: vaccine ovarian | Open Studies - List Results - ClinicalTrials.gov 25 open studies)

›
Found 25 studies with search of: vaccine ovarian | Open Studies
Sunday, January 22, 2012

Vaccines to boost immunity where it counts, not just near shot site | e! Science News

›
"It should not be long because all the individual cytokines (immune system factors) and additional materials loaded into these particl...
Thursday, January 12, 2012

Heat Biologics: Vaccine biotech Heat Bio lands $250K; plans trials for bladder, ovarian cancers

›
"Heat (Biologics) is in phase 2 clinical trials studying its vaccine candidate HS-110 to treat non-small cell lung cancer. The company...
Tuesday, January 03, 2012

Medical Daily: Ovarian Cancer Vaccines Can be Made More Quickly

›
Saturday, August 06, 2011

Cancers | Free Full-Text | Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines (including ovarian cancer)

›
Download PDF Full-Text [270 KB, uploaded 5 August 2011 17:58 CET]
Thursday, June 09, 2011

abstract & full free access: Impact of tumour volume on the potential efficacy of therapeutic vaccines | Gulley | Current Oncology

›
Abstract: Impact of tumour volume on the potential efficacy of therapeutic vaccines J.L. Gulley, MD PhD * , R.A. Madan, MD * , J. Sc...
Monday, February 28, 2011

Recommended Adult Immunization Schedule --- United States, 2011 including those with health conditions- Fig. 2

›
FIGURE 2. Vaccines that might be indicated for adults, based on medical and other indications --- United States, 2011 Alternate Text: ...
Sunday, February 20, 2011

Long-term clinical and immunological effects of p53-SLP® vaccine in ovarian cancer patients

›
Abstract Vaccine-induced p53-specific immune responses were previously reported to be associated with improved response to secondary che...
Wednesday, December 22, 2010

Scientists Discover Potential Strategy To Improve Cancer Vaccines

›
Saturday, July 31, 2010

EvidenceUpdates: Cochrane Collaboration review: Vaccines for preventing influenza in healthy adults including professional commentaries and warning

›
CONCLUSIONS: Influenza vaccines have a modest effect in reducing influenza symptoms and working days lost. There is no evidence that they ...
Tuesday, February 02, 2010

Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival.

›